Therapeutic Digests

June 15, 2020

A silver lining of COVID-19 has been the necessary swift exchange of information as a response to a global public health crisis. The speed and volume of the scientific knowledge are correspondingly fast and unprecedented. We are at a unique time when competition among pharma … Read More »

May 15, 2020

The simultaneous advances in biotechnology, material sciences, synthetic chemistry, and information technology are integrating to provide novel approaches to insulin-dependent diabetes that were impossible as recent as a decade ago. With more than half a billion people affec … Read More »

April 15, 2020

Despite lingering controversy, use of botanical cannabis for medicinal purposes represents the revival of a plant with historical significance reemerging in present-day healthcare.  Ultimately, as the medicinal cannabis landscape continues to evolve, practices from hospitals … Read More »

March 15, 2020

Currently, there are 5.1 million people with Alzheimer’s disease in the United States and 13 million worldwide. In 30 years, AD is expected to affect 13 million in the US, and more than 100 million worldwide. The cost of care for AD in the US is currently estimated at $267 b … Read More »

February 15, 2020

Within the mental health category, progress is being driven by FDA initiatives to encourage novel submissions, the engagement of pharmaceutical companies to assess biomarkers through development and approval, as well as the academic research conducted by the consortia of psy … Read More »

January 15, 2020

Gene therapy is based on two basic strategies: an integrating vector that is introduced into a stem cell so that the gene integrates at one or more places in the patient’s chromosomes, also known as ex vivo; and gene delivery into a nonintegrating vector to a long-lived post … Read More »

FEEDBACK